Lumos Pharma | NLNK - Zahlungsmittel Und Äquivalente



Zahlungsmittel Und Äquivalente Veränderung Datum
Agenus USD 18.74M 16.26M 2026-06
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Capricor Therapeutics USD 20.94M 84.49M 2026-06
Celldex Therapeutics USD 47.45M 11.72M 2026-06
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Eli Lilly USD 8.95B 3.67B 2026-06
Grifols EUR 979.78M 334.84M 2024-12
Incyte USD 3.98B 33.45M 2026-06
Intrexon USD 9.34M 1.77M 2024-06
Merck USD 6.85B 1.52B 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Pfizer USD 976M 727M 2026-06
Prothena USD 288.19M 41.27M 2026-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06